New pill tested to tame uncontrollable hives
NCT ID NCT06865651
Summary
This study is testing whether an investigational oral drug called remibrutinib can better control the symptoms of chronic hives compared to a placebo. It will involve about 44 adults whose hives are not well-managed by standard antihistamine medications. Participants will take either the study drug or a placebo for 12 weeks to see if it reduces itching, pain, and burning and improves their quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Endeavor Health
RECRUITINGGlenview, Illinois, 60077, United States
Contact Email: •••••@•••••
Contact
-
Novartis Investigative Site
RECRUITINGGrenoble, 38043, France
-
Novartis Investigative Site
RECRUITINGMontpellier, 34295, France
-
Novartis Investigative Site
RECRUITINGParis, 75970, France
-
Novartis Investigative Site
RECRUITINGPierre-Bénite, 69495, France
-
Novartis Investigative Site
RECRUITINGDresden, Saxony, 01307, Germany
-
Novartis Investigative Site
RECRUITINGBerlin, 13353, Germany
-
Novartis Investigative Site
WITHDRAWNMainz, 55131, Germany
-
Novartis Investigative Site
RECRUITINGTübingen, 72076, Germany
-
Novartis Investigative Site
RECRUITINGPoznan, 61-731, Poland
-
Novartis Investigative Site
RECRUITINGRzeszów, 35 055, Poland
-
Novartis Investigative Site
RECRUITINGWarsaw, 02-962, Poland
-
Novartis Investigative Site
RECRUITINGBarcelona, Catalonia, 08003, Spain
-
Novartis Investigative Site
RECRUITINGPamplona, Navarre, 31008, Spain
-
Novartis Investigative Site
RECRUITINGAlicante, 03010, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28006, Spain
-
Ziaderm Research LLC
RECRUITINGNorth Miami Beach, Florida, 33162, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.